Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CareCloud (CCLD) Research & Development (2016 - 2026)

CareCloud has reported Research & Development over the past 13 years, most recently at $2.5 million for Q4 2025.

  • Quarterly Research & Development rose 151.04% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Dec 2025, up 68.79% year-over-year, with the annual reading at $6.4 million for FY2025, 68.79% up from the prior year.
  • Research & Development was $2.5 million for Q4 2025 at CareCloud, up from $1.6 million in the prior quarter.
  • Over five years, Research & Development peaked at $5.9 million in Q4 2022 and troughed at $80000.0 in Q4 2021.
  • The 5-year median for Research & Development is $1.1 million (2022), against an average of $1.4 million.
  • Year-over-year, Research & Development tumbled 96.75% in 2021 and then skyrocketed 7336.25% in 2022.
  • A 5-year view of Research & Development shows it stood at $80000.0 in 2021, then skyrocketed by 7336.25% to $5.9 million in 2022, then plummeted by 79.61% to $1.2 million in 2023, then decreased by 16.49% to $1.0 million in 2024, then soared by 151.04% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for CCLD's Research & Development are $2.5 million (Q4 2025), $1.6 million (Q3 2025), and $1.0 million (Q2 2025).